Home Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration
 

Keywords :   


Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration

2015-10-14 06:26:33| drugdiscoveryonline News Articles

Eli Lilly and Company (NYSE: LLY) and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

Tags: collaboration announce lilly preclinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07July/August 2024 Digital Edition of National Hog Farmer now available
01.07Mexico market immersion with USMEF
01.07Iowa man gets six-month sentence for wire fraud scheme of pork producers
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 12A
01.07Kimberly-Clark Sells Bolivian Operations
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
More »